News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SV7 Impact Medicine Fund LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/03/2021 |
4/A
| SV7 Impact Medicine Fund LP (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Converted 998,544 shares
@ $0
Converted 998,544 shares
@ $0
Converted 302,588 shares
@ $0
Converted 302,588 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Bought 312,500 shares
@ $16, valued at
$5M
Converted 9,486,166 convertible preferred
@ $0
Converted 9,486,166 convertible preferred
@ $0
Converted 2,874,595 convertible preferred
@ $0
Converted 2,874,595 convertible preferred
@ $0 |
|
| 11/03/2021 |
SC 13D
| SV7 Impact Medicine Fund LP reports a 6% stake in XILIO THERAPEUTICS, INC. |
| 10/28/2021 |
4
| SV7 Impact Medicine Fund LP (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Converted 998,544 shares
@ $0
Converted 998,544 shares
@ $0
Converted 302,588 shares
@ $0
Converted 302,588 shares
@ $0
Converted 9,486,166 convertible preferred
@ $0
Converted 9,486,166 convertible preferred
@ $0
Converted 2,874,595 convertible preferred
@ $0
Converted 2,874,595 convertible preferred
@ $0 |
|
| 10/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|